SYN - Theriva Biologics Inc
Previous close
1.0305
0 0%
Share volume: 0
Last Updated: Thu 13 Oct 2022 06:00:00 AM CEST
Pharmaceutical Preparation Manufacturing :
-2.88%
PREVIOUS CLOSE
CHG
CHG%
$1.03
0.00
0.00%
Summary score
41%
Profitability
50%
Dept financing
4%
Liquidity
31%
Performance
44%
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
Long-term ratios 30-Jun-2016 - 30-Jun-2020
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-40.2%
Return on assets
-36.1%
Return on sales
0%
Return on invested capital
115.01%
Total debt ratio
40.27%
Debt ratio change over timeo
-0.03%
Current Ratio
3.13%
Quick Ratio
0%
Cash Position Ratio
3.22%
Short-term ratios 30-Jun-2019 - 30-Jun-2020
The data are presented for the financials results of the quarters of the last year.
Return on equity
-30.02%
Return on assets
-24.88%
Return on sales
0%
Return on invested capital
114.69%
Total debt ratio
11.32%
Debt ratio change over timeo
-0.91%
Current Ratio
3.28%
Quick Ratio
0%
Cash Position Ratio
3%
Last quarter ratios 30-Jun-2020
The data are presented for the financials results of the last quarter.
Return on equity
-38.17%
Return on assets
-30.15%
Return on sales
0%
Return on invested capital
118.52%
Total debt ratio
9.17%
Debt ratio change over time
-0.94%
Current Ratio
2.61%
Quick Ratio
0%
Cash Position Ratio
2.35%
Performance ratios (change over 4 years) 30-Jun-2016 - 30-Jun-2020
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-256.99%
Return on assets
-158.8%
Return on sales
0%
Return on invested capital
18.66%
Total debt ratio
-3.49%
Debt ratio change over time
-0.03%
Current Ratio
1.95%
Quick Ratio
0%
Cash Position Ratio
1.65%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | SYN | VLON | ELAT | RETA |
|---|---|---|---|---|
| Return on equity | -40.2% | 0% | 0% | 29.06% |
| Return on assets | -36.1% | 0% | 0% | -9.75% |
| Return on sales | 0% | 0% | 0% | -1469.44% |
| Return on invested capital | 115.01% | 0% | 0% | 47.78% |
| Profitability | 50% | 0% | 25% | 35% |
| Total debt ratio | 40.27% | 0% | 0% | 183.15% |
| Debt ratio change over time | -0.03% | 0% | 0% | 19.02% |
| Dept financing | 5% | 0% | 0% | 50% |
| Current Ratio | 3.28% | 0% | 0% | 5.9% |
| Quick Ratio | 0% | 0% | 0% | 5.9% |
| Cash Position Ratio | 3% | 0% | 0% | 5.68% |
| Liquididy | 40% | 0% | 0% | 75% |
| Short-term ratios | SYN | VLON | ELAT | RETA |
|---|---|---|---|---|
| Return on equity | -30.02% | 0% | 0% | -16.12% |
| Return on assets | -24.88% | 0% | 0% | -14.95% |
| Return on sales | 0% | 0% | 0% | -3498.94% |
| Return on invested capital | 114.69% | 0% | 0% | 96.56% |
| Profitability | 50% | 0% | 50% | 21% |
| Total debt ratio | 11.32% | 0% | 0% | 79.61% |
| Debt ratio change over time | -0.91% | 0% | 0% | 0.09% |
| Dept financing | 4% | 0% | 0% | 50% |
| Current Ratio | 3.28% | 0% | 0% | 5.9% |
| Quick Ratio | 0% | 0% | 0% | 5.9% |
| Cash Position Ratio | 3% | 0% | 0% | 5.68% |
| Liquididy | 27% | 0% | 0% | 75% |